David Allan
Direttore/Membro del Consiglio presso Life Sciences Ontario
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
James Parsons | M | 58 | 14 anni | |
Thomas Wellner | M | 59 |
Life Sciences Ontario
| - |
Matthew David Houston | M | 60 |
YM Biosciences USA, Inc.
YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | 19 anni |
Jason Field | M | - |
Life Sciences Ontario
| - |
Paul Mesburis | M | 54 | 8 anni | |
Michael Giuffre | M | 68 | 14 anni | |
Richard Pilnik | M | 67 | 15 anni | |
Garrett Herman | M | 79 |
Loewen, Ondaatje, McCutcheon Ltd.
Loewen, Ondaatje, McCutcheon Ltd. Investment Banks/BrokersFinance Loewen, Ondaatje, McCutcheon Ltd. (LOM) is an independent Canadian broker/dealer firm headquartered in Toronto, Ontario. Founded in 1970, the firm combines objective research and value-added financing ideas with institutional sales, trading and investment banking. They are a provider of value-added North American research. LOM focuses exclusively on advising small and mid-cap companies, with a strong focus on select emerging growth companies in industries that include Technology, Healthcare, and Mining. | 34 anni |
Robert B. Montgomery | M | 61 |
OCAD University
| - |
Bernard West | M | - |
Life Sciences Ontario
| - |
David P. Holland | M | 66 |
OCAD University
| - |
John Albright | M | - |
OCAD University
| - |
Benjamin Rovinski | M | 67 |
Life Sciences Ontario
| - |
R. Raja Khanna | M | 51 |
OCAD University
| - |
Raf Hofstein | M | 74 |
Life Sciences Ontario
| - |
Deborah Brown | F | - |
Life Sciences Ontario
| - |
John A. Vivash | M | - |
OCAD University
| - |
Myrna Francis | M | 73 |
OCAD University
| 8 anni |
Mark Smithyes | M | 55 |
Life Sciences Ontario
| - |
Ana Serrano | F | - |
OCAD University
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Niclas Stiernholm | M | - | 8 anni | |
Calvin Stiller | M | 83 | 8 anni | |
Robert A. Uger | M | 53 | 8 anni | |
Rick Franklin | M | 78 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 11 anni |
Amin I. Khalifa | M | 70 | 6 anni | |
Robert P. Hickey | M | 78 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 15 anni |
Robert L. Kirkman | M | 75 | 8 anni | |
Pieter de Visser | M | 74 | 2 anni | |
Gail Schulze | F | 72 |
YM Biosciences USA, Inc.
YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | 1 anni |
Wayne Lautt | M | - | 9 anni | |
Henry Friesen | M | 90 | - | |
Dawson J. Reimer | M | 53 | 5 anni | |
Robert Cross | M | 65 |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 2 anni |
Penka Petrova | M | 56 | 8 anni | |
Michael G. Moore | M | - | 7 anni | |
Vanessa Grant | F | - | - | |
Joerg Gruber | M | 63 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 4 anni |
Mark Robbins | M | - | 3 anni | |
Michael Cook | M | - | 1 anni | |
Beverly Incledon | M | - | - | |
Reggie Bowerman | M | - | - | |
Stephen J. Waters | M | - | - | |
John S. Hoffer | M | - |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 6 anni |
John Benson | M | 62 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 5 anni |
Scott Duncan | M | - | - | |
Corinne Mundin | F | - |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 3 anni |
Ted Kolodka | M | - | - | |
Albert Agro | M | 59 | - | |
April Manness | F | - | - | |
Jerry Vickers | M | - |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 4 anni |
Albert Friesen | M | 77 | 1 anni | |
Eli Pines | M | 78 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 anni |
Gordon Keep | M | 67 |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 10 anni |
Walter R. Maupay | M | 84 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 15 anni |
Dan Stearne | M | - | 1 anni | |
John Grandy | M | - |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 9 anni |
Bradley Humphrey | M | - |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 2 anni |
Geoff Whitlam | M | - |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 8 anni |
Karl-Gunnar Hidinger | M | - | 1 anni | |
Peter G. Milner | M | 68 | - | |
Mark Lawrence | M | - |
Loewen, Ondaatje, McCutcheon Ltd.
Loewen, Ondaatje, McCutcheon Ltd. Investment Banks/BrokersFinance Loewen, Ondaatje, McCutcheon Ltd. (LOM) is an independent Canadian broker/dealer firm headquartered in Toronto, Ontario. Founded in 1970, the firm combines objective research and value-added financing ideas with institutional sales, trading and investment banking. They are a provider of value-added North American research. LOM focuses exclusively on advising small and mid-cap companies, with a strong focus on select emerging growth companies in industries that include Technology, Healthcare, and Mining. | 5 anni |
Marc R. Sportsman | M | 69 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 2 anni |
Barry Frankel | M | 73 |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | 8 anni |
Robert Sibthorpe | M | 75 |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 10 anni |
Catherine McLeod-Seltzer | F | 63 |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 8 anni |
Djenane Cameron | F | - |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 1 anni |
John Skinner | M | - |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks | 15 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Canada | 33 | 49.25% |
Stati Uniti | 26 | 38.81% |
Regno Unito | 10 | 14.93% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- David Allan
- Contatti personali